New Search

If you are not happy with the results below please do another search

1 search result for:

1

Investors inject €2 million into Abviris to boost HPV cancer biomarker expansion

Abviris Deutschland, a biotech company, has received an injection of €2 million from existing investors to speed up expansion. The move comes after the publication of highly promising results for its pioneering immunoassay biomarker as an aid in the early diagnosis of head, neck and anogenital cancers caused by human papilloma viruses (HPV).